OBJECTIVE: The aim of this study was to determine the correlation between the number of FOXP3 + T cell in lesions and the disease activity of patients with oral lichen planus (OLP). MATERIALS AND METHODS: The expression of FOXP3 was investigated using immunohistochemical staining and real-time RT-PCR in 23 OLP lesions and 12 controls. Changes of FOXP3 + Treg in peripheral blood from three patients' pre and post-treatment were assessed using flow cytometry. RESULTS: Few FOXP3 + cells were detected in controls, but an increased number of FOXP3 + cells were observed in lesions (n = 20, 40.99 ± 24.68 cells per high-power field -hpf). Furthermore, the frequency of FOXP3 + Treg in reticular OLP (n = 7, 63.6 ± 23.2 cells per hpf) was significantly higher than that in erythematous ⁄ erosive OLP (n = 13, 28.8 ± 16.8 cells per hpf, P = 0.001). In addition, negative correlation was found between the number of FOXP3 + Treg and disease activity (correlation oefficient = )0.557, P = 0.013). The proportion of FOXP3 + Treg showed remarkable increase in peripheral blood from patients after treatment (1.39 ± 0.71% vs 4.91 ± 1.59%). CONCLUSIONS: These data indicated that FOXP3 + Treg were involved in the pathogenesis of OLP and correlated with disease's subtype and activity. Oral Diseases (2010) 16, 76-82
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.